Development of a cross-protective L2-based vaccine against bovine papillomavirus and assessment of its safety and immunogenicity in cattle

Ähnliche Einträge

• Development of a cross-protective L2-based vaccine against oncogenic human papillomaviruses
  von: Seitz, Hanna
  Veröffentlicht: (2013)
• Development of a cross protective vaccine against papillomavirus infection based on the minor structural protein L2
  von: Rubio Sierra, Arleth Ivonne
  Veröffentlicht: (2009)
• Immunogenicity and safety of H1N1 vaccination in anorexia nervosa
  Veröffentlicht: (2012)
• The impact of epitope-linking spacers on the structure and immunogenicity of a prophylactic antigen against human papillomavirus
  von: Zhang, Yueru
  Veröffentlicht: (2023)
• Preclinical immunogenicity and safety of the cGMP-grade placental malaria vaccine PRIMVAC
  von: Chêne, Arnaud, et al.
  Veröffentlicht: (2019)